It’s time to start thinking about fall virus protection, the CDC and FDA ... vaccine, with a 2-month interval since the last dose of any COVID vaccine. The recommendations for the RSV vaccine ...
The decision clears ... an updated COVID-19 vaccine to provide better protection against currently circulating variants," said Dr. Peter Marks, Director of the FDA's Center for Biologics ...
The FDA in May 2023 approved both vaccines for use in older adults, a decision regarded ... with contracting RSV, and found the costs varied by age group and type of vaccine.
All vaccines authorized by the FDA this summer -- Moderna, Pfizer and Novavax -- target a strain of virus that is a better match for the one currently circulating than the vaccine strain from last ...
A third U.S. manufacturer, Novavax, expects its modified vaccine version to ... circulating variants,” said FDA vaccine chief Dr. Peter Marks. The agency’s decision came a bit earlier than ...
but the FDA should engage more effectively as well. The decision prolongs — probably for a decade — the availability of much-needed treatments. It is harmful, for all the veterans and millions ...
There are certain types of clinical studies that would not support exclusivity, and Liquidia argues this includes the study that the FDA has based its decision on. "FDA exceeded its statutory ...
The U.S. Food and Drug Administration (FDA) has approved updated COVID-19 vaccines from Moderna and Pfizer for the 2024-2025 season. The updated mRNA vaccines, Comirnaty and Spikevax, were fully ...
Moderna has vowed to cut annual R&D spending by $1.1 billion by 2027. The decision to shrink the budget by more than 20% follows commercial setbacks that have persuaded the biotech to take a “more ...
“Vaccination continues to be the cornerstone of COVID-19 prevention,” said Peter Marks, director of the FDA’s Center for ... Novavax, whose vaccine hasn't yet been approved this year ...
The Drug Enforcement Administration has scheduled a hearing on the Biden administration’s proposal to reclassify marijuana under federal drug laws, effectively delaying the decision until after ...